Jaarrekening.be

Company information

Search for companies, directors, annual accounts, and financial ratios.

Risk analysis

Health scores, signals, credit assessment, and due diligence.

Monitoring and alerts

Follow companies, receive daily alerts and find new leads.

For the self-employed For companies For accountants For notaries For legal professionals For investors For suppliers For consultants For banks For journalists

For the self-employed

Search a company by name or VAT number and see the Health score from 1 to 5, calculated on the annual accounts filed with the National Bank. No accountant or prior knowledge needed.

More about this solution

For companies

Sales, finance and credit control work on the same lists, with the figures from the National Bank and the CBE.

More about this solution

For accountants

Follow the filings of all your client files, compare their ratios with the sector and see who holds a mandate in which company.

More about this solution

For notaries

Directors, shareholders, amendments to the articles and the latest annual accounts of every Belgian company, from the CBE, the Official Gazette and the National Bank.

More about this solution

For legal professionals

See the latest annual accounts, the directors and their other mandates of a client or counterparty. Before the first meeting you know who you are dealing with and whether a claim is worth pursuing.

More about this solution

For investors

See the profit, equity, debts and directors of a Belgian SME from the filed annual accounts, before the first meeting with the founders.

More about this solution

For suppliers

Look up the customer by name or enterprise number, check the Health score and the suggested credit limit, then follow it in your watchlist.

More about this solution

For consultants

Build the list of every player in a sector and region and see where each company stands against its sector peers. The figures come from the annual accounts filed with the National Bank and go straight to Excel.

More about this solution

For banks

Credit analysts, leasing companies and credit insurers see the Health score, ratios and directors of every Belgian company. Through the API you pull the same data into your own scoring model, with a monthly allowance per plan and additional packages.

More about this solution

For journalists

Directors, shareholders, figures and Official Gazette publications of every Belgian company, on one page.

More about this solution

Insights

Articles on reading annual accounts, ratios and bankruptcy risk.

View all insights →

Guides

Step by step: company lists, monitoring, exports and comparisons.

View all guides →

Featured

Bankruptcies in Belgium, the figures by month, sector and province

Log in Start free

Guides Pricing Company information Risk analysis Monitoring and alerts Log in Register

Marc Dechamps

Waterloo, Belgium Search on LinkedIn

Equity: € 18.89M; Direct: € 15.38M
Profit: € -3.53M; Direct: € 5.64M
Companies: 37; Direct: 4
Employees: 19; Direct: 0

These figures are the sum of the linked companies and do not represent the personal wealth or income of this person.

Companies 4

Enterprise	Health	Equity	Turnover	Employees	Net profit	Assets
Xmf 0659.744.114 · Director · since July 2016	2.7	€ 19K	-	-	€ 135K	€ 210K
Biogencell Europe Sa 0678.674.356 · Director	2.6	€ 61K	-	-	€ -9K	€ 387K
Orsa Tech 0882.104.835 · Chairman of the board of directors · since October 2021	4.93	€ 12.95M	-	-	€ 3.00M	€ 38.69M
Investsud Innovation 1010.817.994 · Director · since June 2024 · mandate until June 2029	3.8	€ 2.35M	-	-	€ 37K	€ 2.36M

Corporate structure

Mandates and holdings

X XMF 0659.744.114

B BIOXODES 0825.151.779

BE BioGenCell Europe SA 0678.674.356

OT ORSA TECH 0882.104.835

NOVADIP BIOSCIENCES

NOVADIP BIOSCIENCES 0535.575.602

0.94%

B BIOWIN 0882.768.591

SM SYNERGIA MEDICAL 0540.563.776

11.33%

W Wishbone 0543.516.635

3.24%

B BIO-SOURCING 0554.840.790

2.56%

PL PDC line Pharma 0657.842.221

2.75%

Newton Biocapital I, pricaf privée de droit belge

Newton Biocapital I, pricaf privée de droit belge 0674.831.275

2.64%

SM SYNERGIA MEDICAL 0540.563.776

14.67%

ET EPICS THERAPEUTICS 0690.759.071

22.87%

SM Sequana Medical 0707.821.866

3.89%

D DeuterOncology 0754.971.388

72.2%

NB NEUVASQ BIOTECHNOLOGIES 0762.966.663

16.82%

AH Aboleris Holdco 0803.217.012

31.14%

D Dim3 0862.997.221

34.4%

AT ATB THERAPEUTICS 0677.980.015

24.14%

ET EPICS THERAPEUTICS 0690.759.071

4.38%

C CURVO 0733.642.969

6.24%

R RUMEXPERTS 0742.532.822

7.1%

A AGRICELLS 0742.991.393

11.17%

VI Vives Inter-University Fund 0750.788.908

0.53%

S SPINOVIT 0780.784.375

S Sunrise 0632.607.373

8.81%

AT ATB THERAPEUTICS 0677.980.015

4.97%

V VOCSens 0721.610.714

12.1%

EB ExeVir Bio 0750.495.334

4.47%

NT NeGIO Therapeutics 0799.822.012

12.55%

S Stellaris 0804.341.222

20.02%

B BiocSol 1003.683.546

21.76%

D DeuterOncology 0754.971.388

7.85%

OO OCTIMET Oncology 0651.853.757

100%

NB NEUVASQ BIOTECHNOLOGIES 0762.966.663

0.56%

NB Newton Biocapital II 0779.335.513

3.96%

ST Santero Therapeutics 0765.790.155

8.56%

AT AUGUSTINE THERAPEUTICS 0722.705.230

3.32%

C Cellaïon 0764.522.425

16.19%

NT NeGIO Therapeutics 0799.822.012

1.79%

AH Aboleris Holdco 0803.217.012

1.14%

S Stellaris 0804.341.222

3.89%

O OPAL-SYSTEMS 0821.605.044

14.2%

B BIOXODES 0825.151.779

12.7%

IM ISTAR MEDICAL 0828.058.712

2.34%

II INVESTSUD INNOVATION 1010.817.994

AT ATB THERAPEUTICS 0677.980.015

0.9%